Organogenesis Holdings Inc. balance sheet

At the end of fiscal 2025, Organogenesis Holdings Inc. had total assets of $599m, total liabilities of $165m and shareholders' equity of $300m. It held $93.7m in cash against $0 of debt: net cash of $93.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Organogenesis Holdings Inc.: balance sheet, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	2	2	21	60	84	114	102	104	136	94	46
Receivables	—	28	34	39	57	82	89	82	110	217	101
Inventory	—	14	13	23	28	25	25	28	26	30	29
Total current assets	1	50	71	126	174	227	223	225	286	362	200
Goodwill	—	26	26	26	29	29	29	29	29	29	29
Total assets	311	149	164	221	290	443	449	460	498	599	406
Accounts payable	—	19	19	28	23	29	32	31	29	32	29
Total current liabilities	0	52	56	60	68	83	75	81	77	100	57
Long-term debt	—	52	13	50	70	74	71	67	—	—	—
Total debt	0	57	29	50	70	74	71	67	0	0	0
Total liabilities	11	157	117	165	148	202	184	181	113	165	118
Shareholders' equity	−16	−15	40	52	142	241	266	279	263	300	148
Non-controlling interests and other (assets − liabilities − equity)	316	7	7	—	—	—	—	—	122	134	140
Net debt (negative = net cash)	−2	55	8	−11	−14	−40	−31	−37	−136	−94	−46
Shares outstanding	—	67m	—	105m	128m	129m	131m	131m	126m	127m	129m

US$ millions unless shown otherwise. Fiscal quarters.

Organogenesis Holdings Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	101	110	103	120	169	217	117	101
Inventory	27	26	29	33	40	30	28	29
Total current assets	239	286	268	260	300	362	269	200
Goodwill	29	29	29	29	29	29	29	29
Total assets	446	498	467	461	510	599	520	406
Accounts payable	24	29	25	30	40	32	29	29
Total current liabilities	77	77	65	66	90	100	76	57
Long-term debt	62	—	—	—	—	—	—	—
Total debt	62	—	—	—	—	—	—	—
Total liabilities	168	113	99	100	124	165	139	118
Shareholders' equity	279	263	243	233	255	300	245	148
Non-controlling interests and other (assets − liabilities − equity)	—	122	125	128	131	134	137	140
Shares outstanding	133m	126m	127m	127m	127m	127m	129m	129m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ORGO vs UFPT MDXG vs ORGO EMBC vs ORGO ORGO vs OSUR

More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies

Figures from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Organogenesis Holdings Inc.